155 related articles for article (PubMed ID: 29544252)
1. Preoperative Examination and Intraoperative Identification of Hepatocellular Carcinoma Using a Targeted Bimodal Imaging Probe.
Jin Y; Wang K; Tian J
Bioconjug Chem; 2018 Apr; 29(4):1475-1484. PubMed ID: 29544252
[TBL] [Abstract][Full Text] [Related]
2. A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging.
Sun J; Li X; Chen A; Cai W; Peng X; Li L; Fan B; Wang L; Zhang H; Zhang R
Int J Nanomedicine; 2019; 14():9893-9904. PubMed ID: 31908447
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
4. An NIR-II/MR dual modal nanoprobe for liver cancer imaging.
Ren Y; He S; Huttad L; Chua MS; So SK; Guo Q; Cheng Z
Nanoscale; 2020 Jun; 12(21):11510-11517. PubMed ID: 32428058
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium-loaded calcium phosphate nanoparticles for magnetic resonance imaging of orthotopic hepatocarcinoma and primary hepatocellular carcinoma.
Zhang NN; Lu CY; Shu GF; Li J; Chen MJ; Chen CM; Lv XL; Xu XL; Weng W; Weng QY; Tang BF; Du YZ; Ji JS
Biomater Sci; 2020 Mar; 8(7):1961-1972. PubMed ID: 32064471
[TBL] [Abstract][Full Text] [Related]
6. Integrin α6-Targeted Magnetic Resonance Imaging of Hepatocellular Carcinoma in Mice.
Zhang Y; Zhao J; Cai J; Ye JC; Xiao YT; Mei Y; Zeng MS; Xie CM; Jiang Y; Feng GK
Mol Imaging Biol; 2020 Aug; 22(4):864-872. PubMed ID: 31792839
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention.
Li TR; Yu MH; Huang XB; Yang ZJ; Lu GM; Li YJ
Chin Med J (Engl); 2017 Nov; 130(21):2591-2600. PubMed ID: 29067958
[TBL] [Abstract][Full Text] [Related]
8. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
9. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma.
Zhang C; Zhao Y; Zhang H; Chen X; Zhao N; Tan D; Zhang H; Shi C
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635650
[TBL] [Abstract][Full Text] [Related]
10. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
11. Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal.
Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Yamamoto Y; Morimura R; Ikoma H; Okamoto K; Kamiya M; Urano Y; Otsuji E
Sci Rep; 2021 Sep; 11(1):17946. PubMed ID: 34504174
[TBL] [Abstract][Full Text] [Related]
12. NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe.
Wang B; Tang C; Lin E; Jia X; Xie G; Li P; Li D; Yang Q; Guo X; Cao C; Shi X; Zou B; Cai C; Tian J; Hu Z; Li J
EBioMedicine; 2023 Dec; 98():104880. PubMed ID: 38035463
[TBL] [Abstract][Full Text] [Related]
13. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237
[TBL] [Abstract][Full Text] [Related]
16. Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.
Harrison VS; Carney CE; MacRenaris KW; Waters EA; Meade TJ
J Am Chem Soc; 2015 Jul; 137(28):9108-16. PubMed ID: 26083313
[TBL] [Abstract][Full Text] [Related]
17. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
[TBL] [Abstract][Full Text] [Related]
18. Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors.
Esfahani SA; Heidari P; Kim SA; Ogino S; Mahmood U
Theranostics; 2016; 6(12):2028-2038. PubMed ID: 27698938
[No Abstract] [Full Text] [Related]
19. Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro.
Jing R; Zhou X; Zhao J; Wei Y; Zuo B; You A; Rao Q; Gao X; Yang R; Chen L; Lu Z; Zhou Q; Zhang N; Yin H
Hepatology; 2018 Oct; 68(4):1391-1411. PubMed ID: 29405333
[TBL] [Abstract][Full Text] [Related]
20. Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis.
Deng H; Shang W; Lu G; Guo P; Ai T; Fang C; Tian J
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14526-14537. PubMed ID: 30776888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
